Skip to main content
. 2017 Feb 22;8(18):30039–30049. doi: 10.18632/oncotarget.15613

Table 5. Performance characteristics of the biomarkers for distinguishing pSS/MALT and healthy control subjects.

Biomarker AUC Sensitivity Specificity
Anti-cofilin-1 0.93 0.80 0.90
Anti-α-enolase 0.93 0.90 0.84
Anti-RGI2 0.94 0.90 0.80
Anti-cofilin-1+Anti-α-enolase+Anti-RGI2 0.99 0.95 0.94